Hiroshi Nishina

8PUBLICATIONS
18CO-AUTHORS
Haematological tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 05, 2026
A YAP-TEAD-CTCF Transcriptional Regulatory Axis Associated With the Elimination of Injured Hepatocytes From the Liver.

|Sep 17, 2026
YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations.

|Apr 21, 2026
SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression.

|Apr 07, 2025
INTS15, A Subunit of the Integrator Complex, Plays a Key Regulatory Role in Cell Cycle and Differentiation.

Noriyuki Azuma, Yuki Yamaguchi, Taku Tanaka

|Mar 29, 2022
Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.

Hiroshi Nishina

|Feb 01, 2022
Protein kinase Cα activation switches YAP1 from TEAD-mediated signaling to p73-mediated signaling.

Caleb Kwame Sinclear, Junichi Maruyama, Shunta Nagashima

Pageof 2

Frequent Collaborators

2 joint publications

Yutaka Hata

2 joint publications

Tomohiko Maehama

2 joint publications

Yutaka Suzuki

2 joint publications

Yoshimi Okamoto-Uchida